Table 1.
Studies Reporting Age-Specific Incidence of Diseases Primarily Affecting the Skin in Olmsted County, Minnesota, USA
Source | Study Period | Skin Disease | Age, y | N | Highest Incidence Rate Per 100,000 Person-Years by Age and Sex
|
|||||
---|---|---|---|---|---|---|---|---|---|---|
Age Group, y | Both Sexes | Age Group, y | Female | Age Group, y | Male | |||||
Skin Cancer | ||||||||||
Chuang et al (8) | 1976–1984 | BCC | All | 657 | ≥85 | 950.2 | ≥85 | 927.8 | 75–84 | 1,043.4 |
Christenson et al (9) | 1976–2003 | BCC | ≤40 | 417 | 36–39 | 93 | 36–39 | 99.6 | 36–39 | 86.1 |
Christenson et al (9) | 1976–2003 | SCC | ≤40 | 68 | 36–39 | 17.4 | 36–39 | 12.5 | 36–39 | 22.6 |
Chuang et al (8) | 1976–1984 | SCC | All | 169 | ≥85 | 446.3 | ≥85 | 371.1 | ≥85 | 706.5 |
Gray et al (10) | 1984–1992 | SCC | All | 511 | ≥85 | 874 | ≥85 | 758.4 | ≥85 | 1,286 |
Adaji et al (11) | 2000–2005 | Atypical nevi | All | 631 | 30–39 | 143.1 | 30–39 | 155.5 | 30–39 | 130.4 |
Mirzoyev et al (12) | 1970–2007 | Lentigo maligna | ≥18 | 145 | 70–79 | 28.5 | ≥80 | 12.6 | 70–79 | 51.9 |
Popescu et al (13) | 1950–1985 | CMM | All | 107 | ≥70 | 23.5 | ≥70 | 16.8 | ≥70 | 37.3 |
Resseguie et al (14) | 1950–1974 | CMM | All | 42 | ≥60 | 8.8 | 40–59 | 8 | ≥60 | 15.5 |
Connective Tissue Disease | ||||||||||
Kurland et al (15)a | 1951–1967 | SLE | All | 29 | 45–64 | 9.2 | ≥65 | 13.6 | 45–64 | 12.4 |
Michet et al (16) | 1950–1979 | Definite SLE | All | 258 | ≥65 | 4.8 | 25–44 | 6.3 | ≥65 | 4.5 |
Michet et al (16) | 1950–1979 | Suspected SLE | All | 21 | ≥65 | 4.8 | ≥65 | 7.5 | N/A | N/A |
Nobrega et al (17) | 1950–1959 | Combined SLE | All | 8 | 45–54 | 5.1 | ≥55 | 7.5 | 45–54 | 5.8 |
Nobrega et al (17) | 1960–1965 | Combined SLE | All | 17 | 45–54 | 15.6 | ≥55 | 14.5 | 45–54 | 34.8 |
Ungprasert et al (18) | 1985–2014 | Mixed connective tissue disease | ≥18 | 50 | 60–69 | 3 | 60–69 | 4.3 | 60–69 | 1.6 |
Pillemer et al (19)b | 1976–1992 | Primary Sjögren syndrome | All | 53 | All | 3.2 | 55–64 | 22.7 | ≥75 | 8.7 |
Nannini et al (20) | 1976–2005 | Primary Sjögren syndrome | ≥18 | 105 | 65–74 | 12.7 | 65–74 | 21.8 | ≥75 | 7.5 |
Papulosquamous Disease Including Psoriatic Arthritis | ||||||||||
Icen et al (21) | 1970–2000 | Psoriasis | ≥18 | 1,633 | 60–69 | 94.2 | 50–59 | 90.7 | 60–69 | 115.3 |
Bell et al (22)c | 1980–1983 | Psoriasis | All | 132 | 60–69 | 112.6 | 60–69 | 126.5 | ≥70 | 130.6 |
Wilson et al (23) | 1969–1999 | Psoriatic arthritis | ≥18 | 147 | 50–59 | 9.6 | 50–59 | 10.5 | 30–39 | 12.2 |
Shbeeb et al (24) | 1982–1991 | Psoriatic arthritis | ≥20 | 66 | ≥20 | 6.59 | 40–59 | 13.38 | 20–39 | 10.8 |
Chuang et al (25) | 1969–1978 | Pityriasis rosea | All | 939 | 20–24 | 454 | 20–24 | 523.2 | 20–24 | 305 |
Infections and Infestations | ||||||||||
Guess et al (26) | 1960–1981 | Herpes zoster | <20 | 173 | 15–19 | 63 | 15–19 | 58 | 15–19 | 71 |
Yawn et al (27) | 1996–2001 | Herpes zoster | ≥22 | 1,669 | ≥80 | 1,140 | ≥80 | 910 | ≥80 | 1,070 |
Kawai et al (28)d | 2000–2007 | Herpes zoster | All | 8,017 | ≥80 | 1,070 | All | 3.44 | All | 2.61 |
Chuang et al (29) | 1965–1979 | Herpes progenitalis | All | 392 | 20–24 | 197 | 20–24 | 210 | 20–24 | 170 |
Chuang et al (30) | 1950–1978 | Condyloma acuminatum | All | 746 | 20–24 | 298 | 20–24 | 322 | 20–24 | 247 |
Wentworth et al (31) | 1980–2009 | Cutaneous nontuberculous mycobacterial infection | All | 40 | ≥60 | 2.2 | N/A | N/A | N/A | N/A |
Bailey et al (32) | 1976–2010 | Delusional infestation | All | 64 | ≥80 | 10 | ≥80 | 7.2 | ≥80 | 16.2 |
Other Skin Diseases | ||||||||||
Safavi et al (33) | 1975–1989 | Alopecia areata | All | 292 | 30–39 | 29.3 | 50–59 | 31.4 | 30–39 | 31.3 |
Mirzoyev et al (34) | 1990–2009 | Alopecia areata | All | 530 | 30–39 | 30.1 | 20–29, 40–49 | 27.1 | 30–39 | 37.2 |
Vazquez et al (2) | 1968–2008 | Hidradenitis suppurativa | All | 268 | 20–29 | 13.3 | 20–29 | 18.4 | 20–29 | 7.4 |
Anderson et al (35)e | 1976–2010 | Infantile hemangioma | ≤3 | 999 | ≤3 | 1,640 | 60–89 days | 7,910 | 60–89 days | 3,410 |
Calamia et al (36) | 1960–2005 | Behçet disease | ≥18 | 13 | 18–29 | 0.75 | 18–29 | 1.14 | 30–39 | 0.59 |
Heit et al (37) | 1966–1990 | Venous stasis syndrome | ≥15 | 1,131 | ≥85 | 349.7 | ≥85 | 364.8 | ≥85 | 306.3 |
Heit et al (37) | 1966–1990 | Venous ulcer | ≥15 | 263 | ≥85 | 124.9 | ≥85 | 134.7 | ≥85 | 96.7 |
Kohorst et al (38) | 2000–2010 | Burning mouth syndrome | All | 169 | 80–89 | 48.1 | 70–79 | 70.3 | 70–79 | 18.4 |
Arora et al (39) | 1996–2010 | Leukocytoclastic vasculitis | All | 84 | 60–69 | 9.7 | 60–69 | 9.3 | ≥70 | 10.9 |
Ungprasert et al (40) | 1976–2013 | Isolated cutaneous sarcoidosis | ≥18 | 26 | 40–49 | 1.5 | 40–49 | 2.3 | 60–69 | 1.4 |
Ungprasert et al (40) | 1976–2013 | Systemic sarcoidosis with sarcoidosis-specific cutaneous lesions | ≥18 | 36 | 40–49 | 2 | 50–59 | 3.4 | 40–49 | 1.7 |
Ungprasert et al (40) | 1976–2013 | Systemic sarcoidosis with erythema nodosum | ≥18 | 26 | 40–49 | 1.5 | 40–49 | 2 | 30–39 | 1.1 |
Abbreviations: BCC, basal cell carcinoma; CMM, cutaneous malignant melanoma; N/A, not available; SCC, squamous cell carcinoma; SLE, systemic lupus erythematosus.
Standardized to the 1960 census.
Hole punched in the manuscript copy, but data were not obscured.
Standardized to the 1980 Rochester census.
Highest incidence rate for both sexes was originally reported as cases/1,000 person-years and has been adjusted to cases/100,000 person-years.
ncidence rates were originally reported as cases/100 person-years and have been adjusted to cases/100,000 person-years.